Dorota Bulsiewicz

Dorota Bulsiewicz

Auto-generated profile, based on publicly available information

Dorota Bulsiewicz

Klinika Neonatologii, Patologii i Intensywnej Terapii Noworodka Instytut Pomnik Centrum Zdrowia Dziecka, Międzylesie, Warszawa, Polska

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJustyna Czech-Kowalska
Justyna Czech-Kowalska
JLJulita Latka-Grot
Julita Latka-Grot
DBDorota Bulsiewicz
Dorota Bulsiewicz
MJMaciej Jaworski
Maciej Jaworski
Pawel PludowskiPawel Pludowski
Pawel Pludowski
ADAnna Dobrzanska
Anna Dobrzanska
The optimal vitamin D intake for nursing women is controversial. Deterioration, at least in bone mass, is reported during lactation. This study evaluated whether vitamin D supplementation during lactation enhances the maternal and infant’s vitamin D status, bone mass and body composition. After term delivery, 174 healthy mothers were randomized to receive 1200 IU/d (800 IU/d+400 IU/d from multivitamins) or 400 IU/d (placebo+400 IU/d from multivitamins) of cholecalciferol for 6 months while breastfeeding. All infants received 400 IU/d of cholecalciferol. Serum 25-hydroxyvitamin D [25(OH)D], iPTH, calcium, urinary calcium, and densitometry were performed in mother-offspring pairs after delivery, and at 3 and 6 months later. A total of 137 (79%) (n = 70; 1200 IU/d, n = 67; 400 IU/d) completed the study. 25(OH)D was similar in both groups at baseline (13.7 ng/ml vs. 16.1 ng/ml; P = 0.09) and at 3 months (25.7 ng/ml vs. 24.5 ng/ml; P = 0.09), but appeared higher in the 1200 IU/d group at 6 months of supplementation (25.6 ng/ml vs. 23.1 ng/ml; P = 0.009). The prevalence of 25(OH)D 20 ng/ml in nursing women, while 1200 IU/d appeared more effective, but had no effect on breastfed offspring vitamin D status, or changes in the bone mass and the body composition observed in both during breastfeeding. ClinicalTrials.gov NCT01506557

30 July 2015 in Annals of Nutrition and Metabolism
Verified
Journal Article
Closed access
JCJustyna Czech-Kowalska
Justyna Czech-Kowalska
DGDariusz Gruszfeld
Dariusz Gruszfeld
MJMaciej Jaworski
Maciej Jaworski
DBDorota Bulsiewicz
Dorota Bulsiewicz
JLJulita Latka-Grot
Julita Latka-Grot
ADAnna Dobrzanska
Anna Dobrzanska
Background: High prevalence of vitamin D deficiency in pregnancy is recorded. Aim: To establish determinants of postpartum 25-hydroxyvitamin D (25(OH)D) levels on mothers and offspring. Methods: 25(OH)D level was measured in cord blood and maternal blood collected ≤3 weeks postpartum. Maternal socioeconomic status, vitamin D intake, sun exposure during pregnancy and maternal and neonatal fat mass (FM; dual X-ray absorptiometry) were assessed within 3 weeks postpartum. Results: A total of 174 mother-offspring pairs were enrolled. Maternal 25(OH)D <20 ng/ml was seen in 32 (51%) of summer and 82 (74%) of winter deliveries. Women with 25(OH)D 0.05). Multiple regression analysis revealed the delivery season, prenatal vitamin D intake ≥800 IU/day and duration of supplementation to be the determinants of maternal 25(OH)D level (R2 = 0.26, p < 0.001). Maternal 25(OH)D level, season of birth and duration of maternal supplementation explained 83% of the variance in cord blood 25(OH)D level (R2 = 0.83, p < 0.001). Conclusions: The key determinants of higher maternal vitamin D status were the summer-autumn season of delivery and prenatal use of ≥800 IU/day of vitamin D. The cord blood 25(OH)D level was mainly determined by maternal 25(OH)D level and season of birth.

1 July 2016 in Pediatria Polska
Verified
Journal Article
Closed access
DJDominika Jedlińska
Dominika Jedlińska
JCJustyna Czech-Kowalska
Justyna Czech-Kowalska
KWKatarzyna Wójcicka-Kowalczyk
Katarzyna Wójcicka-Kowalczyk
DBDorota Bulsiewicz
Dorota Bulsiewicz
MRMagdalena Rybkowska
Magdalena Rybkowska
ADAnna Dobrzańska
Anna Dobrzańska
Beckwith-Wiedemann syndrome is an overgrowth syndrome complicated both phenotypically and genetically. The aim of the study is to present a few cases of newborn babies with B-W syndrome in order to let especially neonatologists and pediatrics follow the diagnostic process. It may make it easier for them to suggest the diagnosis of this syndrome. According to an increased risk for embryonal tumor development, the prophylaxis needs to be taken as well. Children with B-W syndrome need a multi-specialty care.